These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


528 related items for PubMed ID: 11105740

  • 21. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
    Thase ME, Blomgren SL, Birkett MA, Apter JT, Tepner RG.
    J Clin Psychiatry; 1997 Jan; 58(1):16-21. PubMed ID: 9055832
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
    Leombruni P, Pierò A, Lavagnino L, Brustolin A, Campisi S, Fassino S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1599-605. PubMed ID: 18598735
    [Abstract] [Full Text] [Related]

  • 27. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
    Zanardi R, Franchini L, Gasperini M, Perez J, Smeraldi E.
    Am J Psychiatry; 1996 Dec 01; 153(12):1631-3. PubMed ID: 8942464
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP, Søgaard J, Roponen P, Behnke K.
    J Clin Psychiatry; 2000 Feb 01; 61(2):95-100. PubMed ID: 10732656
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.
    Gülseren L, Gülseren S, Hekimsoy Z, Mete L.
    Arch Med Res; 2005 Feb 01; 36(2):159-65. PubMed ID: 15847950
    [Abstract] [Full Text] [Related]

  • 34. Are patients who are intolerant to one SSRI intolerant to another?
    Brown WA, Harrison W.
    Psychopharmacol Bull; 1992 Feb 01; 28(3):253-6. PubMed ID: 1480728
    [Abstract] [Full Text] [Related]

  • 35. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
    Newhouse PA, Krishnan KR, Doraiswamy PM, Richter EM, Batzar ED, Clary CM.
    J Clin Psychiatry; 2000 Aug 01; 61(8):559-68. PubMed ID: 10982198
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
    Michelson D, Amsterdam J, Apter J, Fava M, Londborg P, Tamura R, Pagh L.
    Psychoneuroendocrinology; 2000 Feb 01; 25(2):169-77. PubMed ID: 10674280
    [Abstract] [Full Text] [Related]

  • 38. Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study.
    Henry ME, Moore CM, Kaufman MJ, Michelson D, Schmidt ME, Stoddard E, Vuckevic AJ, Berreira PJ, Cohen BM, Renshaw PF.
    Am J Psychiatry; 2000 Sep 01; 157(9):1506-8. PubMed ID: 10964871
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 27.